Literature DB >> 1309613

Viral proteins associated with the Epstein-Barr virus transactivator, ZEBRA.

D A Katz1, R P Baumann, R Sun, J L Kolman, N Taylor, G Miller.   

Abstract

The BamHI Z Epstein-Barr replication activator (ZEBRA) mediates disruption of latency and induction of Epstein-Barr virus (EBV) early gene expression in latently infected lymphocytes. Polyclonal rabbit sera raised against ZEBRA were used to immunoprecipitate ZEBRA-associated proteins (ZAPs). ZAPs of 19, 21, 23, and 42 kDa were coimmunoprecipitated with ZEBRA from extracts of EBV-producing lymphoid cell lines. ZAPs were not recognized directly by the rabbit sera, but they were antigenic for EBV+ human sera. Immunoprecipitation of ZAPs by ZEBRA-specific antisera required the presence of ZEBRA. ZAPs were not coprecipitated with ZEBRA from mouse cells expressing only ZEBRA, from Raji (a cell line in which EBV is unable to complete lytic replication), or from cells treated with inhibitors of viral DNA synthesis. Thus, ZAPs are late EBV-encoded proteins. ZEBRA and ZAPs colocalized to a salt-insoluble nuclear fraction, and both were found extracellularly in crude preparations of virions. ZAPs might function to affect the cellular localization of ZEBRA, to alter its capacity to transactivate, or to influence its target gene specificity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1309613      PMCID: PMC48240          DOI: 10.1073/pnas.89.1.378

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

1.  Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate.

Authors:  J Luka; B Kallin; G Klein
Journal:  Virology       Date:  1979-04-15       Impact factor: 3.616

2.  Recovery of Epstein-Barr virus from nonproducer neonatal human lymphoid cell transformants.

Authors:  G Wilson; G Miller
Journal:  Virology       Date:  1979-06       Impact factor: 3.616

3.  The nuclear protein matrix: isolation, structure, and functions.

Authors:  R Berezney; D S Coffey
Journal:  Adv Enzyme Regul       Date:  1976

4.  Responsiveness of the Epstein-Barr virus NotI repeat promoter to the Z transactivator is mediated in a cell-type-specific manner by two independent signal regions.

Authors:  P M Lieberman; J M Hardwick; S D Hayward
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

5.  Identification of proteins encoded by Epstein-Barr virus trans-activator genes.

Authors:  M Marschall; U Leser; R Seibl; H Wolf
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

6.  The Epstein-Barr virus (EBV) early promoter DR contains a cis-acting element responsive to the EBV transactivator EB1 and an enhancer with constitutive and inducible activities.

Authors:  P Chavrier; H Gruffat; A Chevallier-Greco; M Buisson; A Sergeant
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

7.  Polymorphisms of the region of the Epstein-Barr virus genome which disrupts latency.

Authors:  H B Jenson; G Miller
Journal:  Virology       Date:  1988-08       Impact factor: 3.616

8.  Polymorphic proteins encoded within BZLF1 of defective and standard Epstein-Barr viruses disrupt latency.

Authors:  J Countryman; H Jenson; R Seibl; H Wolf; G Miller
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

9.  Autoregulation of Epstein-Barr virus putative lytic switch gene BZLF1.

Authors:  E Flemington; S H Speck
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

10.  The Epstein-Barr virus early protein EB1 activates transcription from different responsive elements including AP-1 binding sites.

Authors:  G Urier; M Buisson; P Chambard; A Sergeant
Journal:  EMBO J       Date:  1989-05       Impact factor: 11.598

View more
  14 in total

1.  Autostimulation of the Epstein-Barr virus BRLF1 promoter is mediated through consensus Sp1 and Sp3 binding sites.

Authors:  T Ragoczy; G Miller
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

2.  Phosphoacceptor site S173 in the regulatory domain of Epstein-Barr Virus ZEBRA protein is required for lytic DNA replication but not for activation of viral early genes.

Authors:  Ayman El-Guindy; Lee Heston; Henri-Jacques Delecluse; George Miller
Journal:  J Virol       Date:  2007-01-10       Impact factor: 5.103

3.  Stimulus duration and response time independently influence the kinetics of lytic cycle reactivation of Epstein-Barr virus.

Authors:  Jill Countryman; Lyndle Gradoville; Sumita Bhaduri-McIntosh; Jianjiang Ye; Lee Heston; Sarah Himmelfarb; Duane Shedd; George Miller
Journal:  J Virol       Date:  2009-08-05       Impact factor: 5.103

4.  Gene mapping and expression of two immunodominant Epstein-Barr virus capsid proteins.

Authors:  W M van Grunsven; E C van Heerde; H J de Haard; W J Spaan; J M Middeldorp
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

5.  The Epstein-Barr virus Rta protein activates lytic cycle genes and can disrupt latency in B lymphocytes.

Authors:  T Ragoczy; L Heston; G Miller
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

6.  Two 21-kilodalton components of the Epstein-Barr virus capsid antigen complex and their relationship to ZEBRA-associated protein p21 (ZAP21).

Authors:  T R Serio; A Angeloni; J L Kolman; L Gradoville; R Sun; D A Katz; W Van Grunsven; J Middeldorp; G Miller
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

7.  Epstein-Barr virus lytic replication is controlled by posttranscriptional negative regulation of BZLF1.

Authors:  N Prang; H Wolf; F Schwarzmann
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

8.  Role of the epstein-barr virus RTA protein in activation of distinct classes of viral lytic cycle genes.

Authors:  T Ragoczy; G Miller
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

9.  Two phenylalanines in the C-terminus of Epstein-Barr virus Rta protein reciprocally modulate its DNA binding and transactivation function.

Authors:  Lee-Wen Chen; Vineetha Raghavan; Pey-Jium Chang; Duane Shedd; Lee Heston; Henri-Jacques Delecluse; George Miller
Journal:  Virology       Date:  2009-02-15       Impact factor: 3.616

10.  Serine-173 of the Epstein-Barr virus ZEBRA protein is required for DNA binding and is a target for casein kinase II phosphorylation.

Authors:  J L Kolman; N Taylor; D R Marshak; G Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.